Gene expression analysis of glioma and glioblastoma cells revealed that Meis2 was one of the differentially expressed genes and it could be a prognostic biomarker for glioma and glioblastoma development, in addition to with other genes, including Meox2, Pitx2, Nr2e1, and Tfap2B (Vastrad et al., 2017). This evidence concerns the gene TFAP2B and glioma.